Study group | Control group | |||||
---|---|---|---|---|---|---|
Day 1 | Day 7 | Day 14 | Day 1 | Day 7 | Day 14 | |
Platelets | 88 (43–149) | 172 (131–282) | 273 (191–343) | 95 (86–136) | 214 (117–263) | 224 (134–369) |
AST (IU/L) | 24 (16–32) | 24 (19–36) | 30 (20–52) | 29 (18–38) | 26 (21–43) | 39 (23–51) |
ALT (IU/L) | 35 (23–48) | 32 (23–47) | 33 (23–44) | 43 (29–57) | 33 (19–44) | 32 (23–50) |
Creatine (mg/dL)a | 0.96 (0.81–2.12) | 0.54 (0.45–0.84) | 0.48 (0.36–0.63) | 0.92 (0.67–2.65) | 0.68 (0.56–0.90) | 0.60 (0.51–0.67) |
Triglyceride (mg/dL)b | 79 (62–103) | 85 (72–98) | 110 (94–131) | 76 (55–98) | 91 (62–119) | 92 (79–123) |
Cholesterol (mg/dL) | 84 (76–105) | 103 (80–120) | 126 (95–142) | 93 (76–143) | 103 (83–121) | 107 (87–126) |
Bilirubin (mg/dL)c | 1.0 (0.5–1.8) | 0.7 (0.5–1.0) | 0.8 (0.6–0.9) | 1.5 (1.0–2.6) | 1.1 (0.8–2.4) | 1.0 (0.7–1.5) |
Albumin (g/dL) | 2.3 (2.1–2.7) | 2.5 (2.2–2.8) | 2.9 (2.5–3.2) | 2.4 (2.2–2.9) | 2.5 (2.2–2.8) | 2.7 (2.2–3.1) |